Strategy Consulting for Pharma & Biotech.
We work with pharma, biotech, CDMO, MedTech and nutraceutical companies, delivering strategy consulting, portfolio analysis and profitability planning to drive commercial growth.
Execution Proven at Scale.
Before advising clients on India market entry, Provanta built it — as the Official India Partner for HSF Biotech, one of the world's leading nutraceutical ingredient manufacturers. That live, ongoing partnership is the clearest proof of what we deliver.
Our network
Trusted by Global Leaders
Provanta has partnered with and supported some of the world's most respected strategy, consulting, and life sciences organisations.
End-to-End India Market Entry.
Market Entry Strategy
India market intelligence, competitive landscape, go-to-market planning, and partner identification, built for life sciences, not generic markets.
Regulatory Navigation
FSSAI, DCGI, IEC, DGFT: full regulatory pathway design, documentation, and approval management. No delays, no surprises.
Commercial Execution
Distributor selection, channel development, product launch, and commercial operations — we work alongside you to build sustainable revenue.
Business Development
Partner identification, deal structuring, and relationship management across India's pharma and nutraceutical ecosystem.
Operational Excellence
Supply chain setup, distributor management, and fractional commercial leadership — the operational infrastructure that makes growth sustainable.
Strategic Advisory
Ongoing strategic counsel for companies already in India, covering market expansion, portfolio strategy, and commercial optimisation.
A pharma commercialisation firm based in Bengaluru
We help pharma, biotech, CDMO, MedTech and nutraceutical companies enter and grow in India, and we work with clients in the US and EU.
What we do
We take you from market intelligence to launch. That covers market entry strategy, regulatory pathway, commercial execution and business development.
What we have done
60+ engagements delivered, led by a founder with 20+ years of pharma commercialisation. We also built India entry ourselves, as the official India partner for HSF Biotech.
How we work
Scientists and commercial strategists work on the same team, so your science and your business case are checked together. Senior people stay on every engagement through execution.
Why India
India pharma market by 2030, growing at 11% CAGR
Largest pharmaceutical market globally by volume
Of global vaccine supply produced in India
USFDA-approved manufacturing plants outside the US
Built for Life Sciences
Pharmaceuticals
Global pharma companies launching brands in India
Biotechnology
Biotech firms seeking regulatory clarity and partner networks
CDMO / CMO
Contract manufacturers expanding India operations
Medical Devices
Device companies navigating ICMR and hospital channels
AI Drug Discovery
Emerging biotech with first-in-human candidates
Specialty Chemicals
Chemical manufacturers seeking India market access
We Don't Just Advise. We Execute.
Ready to Enter India's Life Sciences Market?
Let's discuss your India opportunity: strategy, regulatory, commercial execution, or all three.